Breadcrumb

Breadcrumbs

Estás en:

Asset Publisher

INFORME INAHTA

Informe completoClinical and cost effectiveness of epithelium-off corneal crosslinking to treat adults and children with keratoconus

Objetivo:  HTW researchers searched for and appraised evidence on the clinical and cost effectiveness of CXL in people with progressive keratoconus. Evidence on CXL procedures that involve removing the corneal epithelium (to allow eye drops to penetrate the cornea) during the procedure (known as ‘epithelium-off’ CXL) was considered. This is an updated version of an appraisal. HTW originally issued Guidance on this topic in February 2018..

Autoría: Health Technology Wales (HTW)

Idioma: inglés

Fuente: INAHTA

Año de publicación: 2021